跳转至内容
Merck
CN
  • Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Psychiatry research (1979-12-01)
G C Davis, A C Williams, S P Markey, M H Ebert, E D Caine, C M Reichert, I J Kopin
PMID298352
摘要

Abuse of 4-propyloxy-4-phenyl-N-methylpiperidine, a meperidine congener, produced parkinsonism in a 23-year-old man. Unlike other drug-induced motor disturbances, the syndrome persisted for 18 months and responded to drugs that stimulate dopamine receptors. Biogenic amines and metabolites in the cerebrospinal fluid and microscopic evaluation of the brain at necropsy were consistent with damage to aminergic neurons in the substantia nigra.